Professional Summary
Professional Overview
Anna McMahon is an accomplished regulatory affairs professional with over 7 years of experience in the biotechnology and pharmaceutical industries. As the Director of Regulatory Affairs at Cellares, she leverages her deep expertise in quality assurance, regulatory compliance, and strategic planning to drive the successful development and commercialization of innovative cell therapy products.
Experience Summary
Current Role
As the Director of Regulatory Affairs at Cellares, Anna is responsible for leading the company's regulatory strategy and ensuring compliance with all relevant guidelines and regulations. She oversees the preparation and submission of regulatory filings, communicates with regulatory agencies, and collaborates cross-functionally to navigate the complex regulatory landscape. Under her leadership, Cellares has successfully navigated the regulatory approval process, enabling the company to bring its groundbreaking cell therapy solutions to market.
Career Progression
Prior to her current role, Anna held several leadership positions in quality and regulatory affairs at BillionToOne, a leading molecular diagnostics company. As the Associate Director and Senior Manager of Quality and Regulatory Affairs, she was instrumental in establishing and maintaining the company's quality management system, developing regulatory strategies, and securing key approvals for their novel genetic testing products. Anna's previous experience also includes roles as a Regulatory Affairs Consultant at FibroGen, Inc. and as a Cell Processing Specialist at Dana-Farber Cancer Institute and Tufts Medical Center, where she gained valuable hands-on experience in stem cell processing and blood banking.
Academic Background
Anna holds a Bachelor of Science degree in Medical Laboratory Science from Northeastern University, where she graduated with distinction. Her specialized knowledge in areas such as cell processing, quality control, and regulatory compliance has been instrumental in her career development and the impact she has made in the biotechnology industry.
Areas of Expertise
- Regulatory strategy development and implementation
- Quality assurance and control systems
- Preparation and submission of regulatory filings (e.g., INDs, BLAs, DMFs)
- Collaboration with cross-functional teams to ensure compliance
- Cell and gene therapy product development and commercialization
- Project management and stakeholder engagement
Professional Impact
During her tenure at Cellares, Anna has played a pivotal role in the company's regulatory success, enabling the timely advancement of their innovative cell therapy platform. Her contributions have been instrumental in securing regulatory approvals and ensuring the company's products meet the highest quality and safety standards. Anna's industry expertise and collaborative approach have earned her a reputation as a trusted leader in the field of regulatory affairs.
Conclusion
With her extensive experience, deep industry knowledge, and proven track record of success, Anna McMahon is a valuable asset to Cellares and the broader biotechnology community. As she continues to drive regulatory excellence and contribute to the development of transformative cell therapy solutions, Anna is poised to make a lasting impact on the field of regenerative medicine.
